These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8101544)

  • 1. Use of newborn liver cells as a murine model for cord blood cell transplantation.
    Davenport C; Kumar V; Bennett M
    J Immunol; 1993 Aug; 151(3):1597-605. PubMed ID: 8101544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An absence of T cells in murine bone marrow allografts leads to an increased susceptibility to rejection by natural killer cells and T cells.
    Murphy WJ; Kumar V; Cope JC; Bennett M
    J Immunol; 1990 May; 144(9):3305-11. PubMed ID: 2329274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rejection of bone marrow cell allografts by natural killer cell subsets: 5E6+ cell specificity for Hh-1 determinant 2 shared by H-2d and H-2f.
    Sentman CL; Kumar V; Bennett M
    Eur J Immunol; 1991 Nov; 21(11):2821-8. PubMed ID: 1718761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid rejection of H2k and H2k/b bone marrow cell grafts by CD8+ T cells and NK cells in irradiated mice.
    Davenport C; Kumar V; Bennett M
    J Immunol; 1995 Oct; 155(8):3742-9. PubMed ID: 7561078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
    Yoshino H; Ueda T; Kawahata M; Kobayashi K; Ebihara Y; Manabe A; Tanaka R; Ito M; Asano S; Nakahata T; Tsuji K
    Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
    Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
    J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor-type activated natural killer cells promote marrow engraftment and B cell development during allogeneic bone marrow transplantation.
    Murphy WJ; Bennett M; Kumar V; Longo DL
    J Immunol; 1992 May; 148(9):2953-60. PubMed ID: 1573278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine cytomegalovirus infection can enhance hybrid resistance through modulation of host natural killer activity.
    Muluk SC; Hakim FT; Shearer GM
    J Immunol; 1990 Aug; 145(4):1113-9. PubMed ID: 2166108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment.
    Blazar BR; Hirsch R; Gress RE; Carroll SF; Vallera DA
    J Immunol; 1991 Sep; 147(5):1492-503. PubMed ID: 1831826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A; Nestel FP; Seemayer TA; Lapp WS
    J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid and allogeneic resistance to T cell grafts mediated by murine NK and CD8+ T cells.
    Davenport C; Haile A; Kumar V; Bennett M
    J Immunol; 1995 Mar; 154(6):2568-77. PubMed ID: 7876533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cell subsets in the regulation of murine hematopoiesis. I. 5E6+ NK cells promote hematopoietic growth in H-2d strain mice.
    Murphy WJ; Raziuddin A; Mason L; Kumar V; Bennett M; Longo DL
    J Immunol; 1995 Sep; 155(6):2911-7. PubMed ID: 7673708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-2-activated murine newborn liver NK cells enhance engraftment of hematopoietic stem cells in MHC-mismatched recipients.
    Hirayama M; Genyea C; Brownell A; Kaplan J
    Bone Marrow Transplant; 1998 Jun; 21(12):1245-52. PubMed ID: 9674859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-NK antibodies injected into recipient mice enhance engraftment and chimerism after allogeneic transplantation of fetal liver stem cells.
    Chargui J; Moya MJ; Sanhadji K; Blanc-Brunat N; Touraine JL
    Thymus; 1997; 24(4):233-46. PubMed ID: 9493286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation.
    Rembecki RM; Bennett M; Kumar V; Potter TA
    J Immunol; 1987 Apr; 138(8):2734-8. PubMed ID: 3549904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice.
    Christianson SW; Greiner DL; Schweitzer IB; Gott B; Beamer GL; Schweitzer PA; Hesselton RM; Shultz LD
    Cell Immunol; 1996 Aug; 171(2):186-99. PubMed ID: 8806787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural antibodies can inhibit bone marrow engraftment in the rat----mouse species combination.
    Aksentijevich I; Sachs DH; Sykes M
    J Immunol; 1991 Dec; 147(12):4140-6. PubMed ID: 1753089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].
    He Y; Wang HH; Wang M; Zhou Z; Zhai WJ; Huang Y; Jiang EL; Wang ZD; Zhou SY; Liu QG; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):82-6. PubMed ID: 16732957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.